Literature DB >> 24252835

Haemophilus influenzae infection of a prosthetic knee joint in a patient with CLL: a vaccine preventable disease.

Sheema Khan1, Srinivasulu Reddy.   

Abstract

A 71-year-old man was admitted with a 2-day history of the hot and swollen right knee in December 2012. He had undergone a primary cemented right total knee replacement (TKR) in 2002. He also had a history of chronic lymphatic leukaemia (CLL), haemolytic anaemia and splenomegaly, and was in partial remission following chemotherapy in 2008. He underwent arthroscopic washout of right TKR on admission. Blood cultures on admission and joint fluid specimen grew Haemophilus influenzae (Hi). The isolate was identified as a non-encapsulated Hi strain by the reference laboratory. Non-encapsulated Hi strains rarely cause invasive disease. CLL with splenomegaly may have predisposed our patient to severe invasive disease. A recently licensed 10-valent pneumococcal vaccine conjugated to the immunogenic outer membrane protein D of Hi could potentially prevent invasive Hi disease. Routine vaccination should be considered in all patients with prosthetic joints and predisposing comorbidities.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24252835      PMCID: PMC3841430          DOI: 10.1136/bcr-2013-010307

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

Review 1.  Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: prepared on behalf of the British Committee for Standards in Haematology by a working party of the Haemato-Oncology task force.

Authors:  John M Davies; Michael P N Lewis; Jennie Wimperis; Imran Rafi; Shamez Ladhani; Paula H B Bolton-Maggs
Journal:  Br J Haematol       Date:  2011-11       Impact factor: 6.998

Review 2.  The diagnosis and management of prosthetic joint infections.

Authors:  E Moran; I Byren; B L Atkins
Journal:  J Antimicrob Chemother       Date:  2010-11       Impact factor: 5.790

3.  No evidence for Haemophilus influenzae serotype replacement in Europe after introduction of the Hib conjugate vaccine.

Authors:  Shamez Ladhani; Mary E Ramsay; Manosree Chandra; Mary P Slack
Journal:  Lancet Infect Dis       Date:  2008-05       Impact factor: 25.071

4.  Invasive Haemophilus influenzae disease in adults.

Authors:  J Sarangi; K Cartwright; J Stuart; S Brookes; R Morris; M Slack
Journal:  Epidemiol Infect       Date:  2000-06       Impact factor: 2.451

5.  Hemophilus influenzae infection of a total hip arthroplasty.

Authors:  T J Limbird
Journal:  Clin Orthop Relat Res       Date:  1985-10       Impact factor: 4.176

6.  Invasive disease due to nontypeable Haemophilus influenzae among children in Arkansas.

Authors:  Joshua M O'Neill; Joseph W St Geme; David Cutter; Elisabeth E Adderson; Juliana Anyanwu; Richard F Jacobs; Gordon E Schutze
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

7.  Analysis of invasive Haemophilus influenzae infections after extensive vaccination against H. influenzae type b.

Authors:  José Campos; Margarita Hernando; Federico Román; María Pérez-Vázquez; Belén Aracil; Jesús Oteo; Edurne Lázaro; Francisco de Abajo
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

Review 8.  Pneumococcal polysaccharide protein D-conjugate vaccine (Synflorix; PHiD-CV).

Authors:  Jamie D Croxtall; Gillian M Keating
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

9.  Guiding empirical antibiotic therapy in orthopaedics: The microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention.

Authors:  E Moran; S Masters; A R Berendt; P McLardy-Smith; I Byren; B L Atkins
Journal:  J Infect       Date:  2007-03-06       Impact factor: 6.072

10.  Invasive Haemophilus influenzae Disease, Europe, 1996-2006.

Authors:  Shamez Ladhani; Mary P E Slack; Paul T Heath; Anne von Gottberg; Manosree Chandra; Mary E Ramsay
Journal:  Emerg Infect Dis       Date:  2010-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.